rs143506822
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_024408.4(NOTCH2):āc.6997G>Cā(p.Ala2333Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000336 in 1,608,350 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A2333V) has been classified as Uncertain significance.
Frequency
Consequence
NM_024408.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152172Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000689 AC: 17AN: 246564Hom.: 0 AF XY: 0.0000450 AC XY: 6AN XY: 133202
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1456060Hom.: 0 Cov.: 32 AF XY: 0.0000152 AC XY: 11AN XY: 723398
GnomAD4 genome AF: 0.000210 AC: 32AN: 152290Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74482
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 30, 2018 | - - |
Hajdu-Cheney syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 27, 2023 | - - |
Hajdu-Cheney syndrome;C1857761:Alagille syndrome due to a NOTCH2 point mutation Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 12, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at